Trial
NCT01703065
Cabozantinib in Men With Castration-Resistant Prostate Cancer
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Washington
Collaborators
Prostate Cancer Foundation; National Cancer Institute (NCI)
Condition
Adenocarcinoma of the Prostate
Intervention
Cabozantinib
Why stopped
Closed 2017 for low accrual. Last data for primary outcome on 02Feb2015.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-12-04